Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Considering And Approving ....

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: July 29, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir/Madam, Sub: Board Meeting Intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that a Meeting of Board of Directors of Amanta Healthcare Limited is scheduled to be held on Wednesday, August 5, 2026, inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. Trading Window: In continuation to our earlier intimation dated June 27, 2026; this is to inform you that the trading window, which was closed from Wednesday, July 1, 2026 in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended; will reopen on Saturday, August 8, 2026. Request you to kindly take same on record. Thanking you, Yours faithfully, For, Amanta Healthcare Limited Nikhita Dinodia Company Secretary Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720